JP7636032B2 - 骨疾患治療用医薬組成物 - Google Patents

骨疾患治療用医薬組成物 Download PDF

Info

Publication number
JP7636032B2
JP7636032B2 JP2023500979A JP2023500979A JP7636032B2 JP 7636032 B2 JP7636032 B2 JP 7636032B2 JP 2023500979 A JP2023500979 A JP 2023500979A JP 2023500979 A JP2023500979 A JP 2023500979A JP 7636032 B2 JP7636032 B2 JP 7636032B2
Authority
JP
Japan
Prior art keywords
cells
mesenchymal stem
stem cells
composition according
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023500979A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022177032A1 (https=
Inventor
健 竹谷
泰昭 小田
有未 伊谷
隆史 陶山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purec Co Ltd
Original Assignee
Purec Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purec Co Ltd filed Critical Purec Co Ltd
Publication of JPWO2022177032A1 publication Critical patent/JPWO2022177032A1/ja
Application granted granted Critical
Publication of JP7636032B2 publication Critical patent/JP7636032B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2023500979A 2021-02-19 2022-02-18 骨疾患治療用医薬組成物 Active JP7636032B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021024794 2021-02-19
JP2021024794 2021-02-19
PCT/JP2022/008103 WO2022177032A1 (ja) 2021-02-19 2022-02-18 骨疾患治療用医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2022177032A1 JPWO2022177032A1 (https=) 2022-08-25
JP7636032B2 true JP7636032B2 (ja) 2025-02-26

Family

ID=82930724

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023500979A Active JP7636032B2 (ja) 2021-02-19 2022-02-18 骨疾患治療用医薬組成物

Country Status (7)

Country Link
US (1) US20240316109A1 (https=)
JP (1) JP7636032B2 (https=)
KR (1) KR20230133892A (https=)
AU (1) AU2022222868B2 (https=)
CA (1) CA3211195A1 (https=)
TW (1) TWI859508B (https=)
WO (1) WO2022177032A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6363950U (https=) 1986-06-17 1988-04-27
JP6463029B2 (ja) * 2013-08-02 2019-01-30 有未 伊谷 ヒト間葉系幹細胞を特異的に認識するモノクローナル抗体並びにこれを用いたヒト間葉系幹細胞の分離及び／または品質評価を行う方法
WO2016017795A1 (ja) 2014-08-01 2016-02-04 有未 伊谷 ヒト間葉系幹細胞の品質評価方法、及び、そのためのモノクローナル抗体
WO2021144995A1 (ja) * 2020-01-16 2021-07-22 ＰｕＲＥＣ株式会社 高純度間葉系幹細胞

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
STEM CELL REPORTS，2013年，Vol.1，pp.152-165
TAKETANI T. et al.，Cell Transplantation，2015年，Vol.24，pp.1931-1943

Also Published As

Publication number Publication date
KR20230133892A (ko) 2023-09-19
AU2022222868A1 (en) 2023-09-07
CA3211195A1 (en) 2022-08-25
JPWO2022177032A1 (https=) 2022-08-25
US20240316109A1 (en) 2024-09-26
WO2022177032A1 (ja) 2022-08-25
TWI859508B (zh) 2024-10-21
TW202302123A (zh) 2023-01-16
AU2022222868B2 (en) 2026-03-19

Similar Documents

Publication Publication Date Title
US8986744B2 (en) Stem cell populations and methods of use
JP2018121650A (ja) 個の医療のための幹細胞バンク
US20130078222A1 (en) Intervertebral Disc Nucleus Pulposus Stem Cell/Progenitor Cell, The Cultivation Method And Intended Use Thereof
US20070243172A1 (en) Multipotent stem cells derived from placenta tissue and cellular therapeutic agents comprising the same
CN101848991A (zh) 分离的细胞群
JPWO2003027281A1 (ja) 骨格筋間質由来多分化能幹細胞
CN108486050B (zh) 从犬的脐带制备间充质干细胞的方法
CN112912087A (zh) 线粒体向淋巴器官中的移植以及用于该移植的组合物
KR20170010894A (ko) 림프구로부터의 다계열 분화능 세포 생성 방법
JPWO2020158924A1 (ja) 母児間免疫寛容を誘導する方法
US11613733B2 (en) Method for purifying mesenchymal stem cells to improve transplantation efficiency
JP7636032B2 (ja) 骨疾患治療用医薬組成物
CN108728408B (zh) 犬胎膜间充质干细胞及制备方法和使用的培养基
CN103585179A (zh) 一种药物组合物及其在制备治疗骨髓造血功能障碍疾病的药物中的应用
US20150353897A1 (en) Method of generating multilineage potential cells
JPH08500009A (ja) 造血促進細胞及びその使用
Ruan et al. Different hematopoietic reconstruction abilities of transplanted cells from bone marrow, spleen, liver and peripheral blood
TW202529782A (zh) 含有高純度間葉系幹細胞之用以治療以及／或是預防粒線體疾病之組成物
US20220370478A1 (en) Composition for enhancing therapeutic effect of stem cell, comprising immunosuppressant, and method for enhancing therapeutic effect of stem cell using same
AU2024354572A1 (en) Composition for treating and/or preventing mitochondrial disease including high-purity mesenchymal stem cells
CN1821272A (zh) 抗人骨髓间充质干细胞单克隆抗体zue12及应用
JP2023063965A (ja) 造血幹細胞含有組成物
Peyer Refining Our Understanding of the Hematopoietic Stem Cell Niche
Katayama et al. Hematopoietic origin of hepatic stellate cells in the adult liver
LI et al. VERFAHREN FÜR OPTIMIERTE EXPANSION UND IMPLANTATION MESENCHYMALER STAMMZELLEN PROCEDES POUR L’EXPANSION ET L’IMPLANTATION OPTIMISEES DE CELLULES SOUCHES MESENCHYMATEUSES

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230525

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20230525

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20230531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230613

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240423

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250128

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250205

R150 Certificate of patent or registration of utility model

Ref document number: 7636032

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150